Philip Charles Hoffman to Dacarbazine
This is a "connection" page, showing publications Philip Charles Hoffman has written about Dacarbazine.
Connection Strength
0.067
-
Phase II trial of temozolomide and irinotecan as second-line treatment for advanced non-small cell lung cancer. J Thorac Oncol. 2006 Mar; 1(3):245-51.
Score: 0.067
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.